This month on Synapse
Paul England introduces the forthcoming Practitioner's Guide to European Patent Law.
Judith Krens and Irenah Klink explore the recent CJEU ruling on the Dutch Medicinal Board’s policy regarding the publication of full package leaflets and summaries of product characteristics of generic medicinal products.
In the first of a series of articles, Paul England outlines the potential impact of personalisation on medicines regulation and exclusivity protection.
Vin Bange asks whether data can be used to discover new medicines, cure diseases and determine the best way for individuals, groups and subgroups to be treated.
Vin Bange and Thanos Rammos explain how data subjects will always have an ultimate master key when it comes to unlocking health data.
